Tianjin Eleli Technology Development
Ordered peptides from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it.
Test my supplyTianjin Eleli Technology Development's purity-focus record is strongest in its broader Retatrutide set, where most vials clear purity and fill despite two 0% purity/0 mg identity failures. GHK-Cu and Tirzepatide are weaker and more dispersed, with recent fill volatility in GHK-Cu and repeated purity plus identity/quantity misses in Tirzepatide.
Source code, product-origin fields and a hidden mail target point beyond the Tianjin storefront to a second operator. The report traces the claimed address, young domain, offshore contact rails, dead Discord invites and unsupported FDA/warehouse claims.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Tianjin Eleli Technology Development rows.
Cancel anytime
Ordered peptides from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
24 Sep 2026 | Fail | TB-500 Tianjin Eleli Technology Development | lab name | View COA | |||
18 Sep 2026 | Pass | BPC-157 Tianjin Eleli Technology Development | lab name | View COA | |||
18 Sep 2026 | Pass | Tirzepatide Tianjin Eleli Technology Development | lab name | View COA | |||
13 Aug 2026 | Fail | TB-500 Tianjin Eleli Technology Development | lab name | View COA | |||
12 Aug 2026 | Fail | BPC-157 Tianjin Eleli Technology Development | lab name | View COA | |||
12 Aug 2026 | Fail | GHK-Cu Tianjin Eleli Technology Development | lab name | View COA | |||
9 Aug 2026 | Pass | Retatrutide Tianjin Eleli Technology Development | lab name | View COA | |||
9 Aug 2026 | Fail | BPC-157 Tianjin Eleli Technology Development | lab name | View COA | |||
9 Aug 2026 | Fail | Tirzepatide Tianjin Eleli Technology Development | lab name | View COA | |||
15 Jul 2026 | Fail | Tesamorelin Tianjin Eleli Technology Development | lab name | View COA | |||
About Tianjin Eleli Technology Development test results from Finnrick
Tianjin Eleli Technology Development is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 43 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Tianjin Eleli Technology Development peptides in this dataset are BPC-157 (6 tests), Cagrilintide (1 test) and GHK-Cu (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 43 recent tests.
Ordered peptides from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it.
Test my supply